BioCardia (BCDA)
(Delayed Data from NSDQ)
$0.38 USD
+0.01 (2.34%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.39 +0.01 (3.56%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for BioCardia, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -11.57 | -11.91 | -12.62 | -15.00 | -14.71 |
Depreciation/Amortization & Depletion | 0.08 | 0.08 | 0.06 | 0.07 | 0.11 |
Net Change from Assets/Liabilities | 0.15 | -0.21 | 0.52 | -0.37 | 1.41 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.36 | 1.48 | 1.68 | 2.94 | 3.74 |
Net Cash From Operating Activities | -9.97 | -10.56 | -10.37 | -12.36 | -9.45 |
Property & Equipment | -0.01 | -0.07 | -0.12 | -0.03 | -0.15 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | -0.07 | -0.12 | -0.03 | -0.15 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.39 | 5.54 | 1.95 | 30.50 | 10.45 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.63 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.66 | -0.42 | 0.00 | -2.29 | -1.26 |
Net Cash from Financing Activities | 3.73 | 5.12 | 1.95 | 28.21 | 9.82 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -6.26 | -5.51 | -8.54 | 15.82 | 0.23 |
Cash at Beginning of Period | 7.36 | 12.87 | 21.41 | 5.59 | 5.36 |
Cash at End of Period | 1.10 | 7.36 | 12.87 | 21.41 | 5.59 |
Diluted Net EPS | -0.55 | -0.67 | -0.75 | -1.48 | -2.61 |
Fiscal Year End for BioCardia, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -11.57 | -9.50 | -6.93 | -3.50 |
Depreciation/Amortization & Depletion | NA | 0.08 | 0.06 | 0.04 | 0.02 |
Net Change from Assets/Liabilities | NA | 0.15 | 0.22 | 0.42 | 0.56 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.36 | 1.09 | 0.75 | 0.36 |
Net Cash From Operating Activities | NA | -9.97 | -8.12 | -5.71 | -2.56 |
Property & Equipment | NA | -0.01 | -0.01 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.01 | -0.01 | -0.01 | -0.01 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 4.39 | 3.04 | 2.95 | 0.06 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.66 | -0.44 | -0.29 | 0.00 |
Net Cash from Financing Activities | NA | 3.73 | 2.61 | 2.67 | 0.06 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -6.26 | -5.53 | -3.06 | -2.51 |
Cash at Beginning of Period | NA | 7.36 | 7.36 | 7.36 | 7.36 |
Cash at End of Period | NA | 1.10 | 1.84 | 4.31 | 4.86 |
Diluted Net EPS | NA | -0.09 | -0.12 | -0.17 | -0.17 |